Suvretta Capital Management as of June 30, 2022
Portfolio Holdings for Suvretta Capital Management
Suvretta Capital Management holds 89 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Royalty Pharma Shs Class A (RPRX) | 4.9 | $129M | 3.1M | 42.04 | |
| UnitedHealth (UNH) | 4.7 | $124M | 241k | 513.63 | |
| Union Pacific Corporation (UNP) | 4.3 | $114M | 532k | 213.28 | |
| Las Vegas Sands (LVS) | 3.7 | $98M | 2.9M | 33.59 | |
| Humana (HUM) | 3.5 | $93M | 198k | 468.07 | |
| Otis Worldwide Corp (OTIS) | 3.5 | $92M | 1.3M | 70.67 | |
| Iqvia Holdings (IQV) | 3.2 | $85M | 392k | 216.99 | |
| Intra Cellular Therapies (ITCI) | 2.9 | $76M | 1.3M | 57.08 | |
| Lauder Estee Cos Cl A (EL) | 2.8 | $75M | 293k | 254.67 | |
| Kura Oncology (KURA) | 2.8 | $74M | 4.0M | 18.33 | |
| Tapestry (TPR) | 2.6 | $69M | 2.2M | 30.52 | |
| Centene Corporation (CNC) | 2.6 | $68M | 807k | 84.61 | |
| Mastercard Incorporated Cl A (MA) | 2.5 | $66M | 209k | 315.48 | |
| Thermo Fisher Scientific (TMO) | 2.5 | $66M | 121k | 543.28 | |
| Microsoft Corporation (MSFT) | 2.4 | $64M | 250k | 256.83 | |
| Visa Com Cl A (V) | 2.4 | $64M | 325k | 196.89 | |
| Mirati Therapeutics | 2.4 | $64M | 952k | 67.13 | |
| Danaher Corporation (DHR) | 2.1 | $55M | 218k | 253.52 | |
| Agios Pharmaceuticals (AGIO) | 2.0 | $52M | 2.3M | 22.17 | |
| Arcellx Common Stock (ACLX) | 1.7 | $45M | 2.5M | 18.08 | |
| AmerisourceBergen (COR) | 1.7 | $45M | 315k | 141.48 | |
| Canadian Pacific Railway | 1.7 | $44M | 634k | 69.84 | |
| Block Cl A (SQ) | 1.6 | $42M | 680k | 61.46 | |
| Insmed Com Par $.01 (INSM) | 1.6 | $41M | 2.1M | 19.72 | |
| Viatris (VTRS) | 1.5 | $41M | 3.9M | 10.47 | |
| Fidelity National Information Services (FIS) | 1.5 | $41M | 443k | 91.67 | |
| Hilton Worldwide Holdings (HLT) | 1.5 | $40M | 361k | 111.44 | |
| Marriott Intl Cl A (MAR) | 1.5 | $40M | 293k | 136.01 | |
| Horizon Therapeutics Pub L SHS | 1.5 | $39M | 487k | 79.76 | |
| Kezar Life Sciences | 1.4 | $37M | 4.4M | 8.27 | |
| McKesson Corporation (MCK) | 1.3 | $34M | 105k | 326.21 | |
| Walt Disney Company (DIS) | 1.3 | $33M | 351k | 94.40 | |
| Global Payments (GPN) | 1.2 | $32M | 287k | 110.64 | |
| Chinook Therapeutics | 1.2 | $31M | 1.8M | 17.49 | |
| Rh (RH) | 1.1 | $28M | 133k | 212.26 | |
| Marqeta Class A Com (MQ) | 1.1 | $28M | 3.5M | 8.11 | |
| Exxon Mobil Corporation (XOM) | 0.9 | $25M | 291k | 85.64 | |
| Sutro Biopharma (STRO) | 0.9 | $24M | 4.6M | 5.21 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.9 | $23M | 3.0M | 7.87 | |
| Gfl Environmental Sub Vtg Shs (GFL) | 0.9 | $23M | 903k | 25.80 | |
| Monster Beverage Corp (MNST) | 0.9 | $23M | 250k | 92.70 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.8 | $21M | 1.1M | 18.65 | |
| Ultragenyx Pharmaceutical (RARE) | 0.8 | $21M | 349k | 59.66 | |
| Point Biopharma Global | 0.8 | $21M | 3.0M | 6.81 | |
| Match Group (MTCH) | 0.8 | $20M | 288k | 69.69 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $19M | 1.9M | 9.84 | |
| Pharvaris N V (PHVS) | 0.7 | $18M | 828k | 22.10 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.6 | $17M | 3.5M | 4.84 | |
| Fulcrum Therapeutics (FULC) | 0.6 | $16M | 3.4M | 4.90 | |
| Servicenow (NOW) | 0.5 | $12M | 26k | 475.53 | |
| Pepgen (PEPG) | 0.4 | $12M | 1.2M | 9.93 | |
| Chimerix (CMRX) | 0.4 | $11M | 5.3M | 2.08 | |
| Metropcs Communications (TMUS) | 0.4 | $11M | 78k | 134.53 | |
| Chevron Corporation (CVX) | 0.4 | $10M | 71k | 144.78 | |
| Mereo Biopharma Group Ads (MREO) | 0.4 | $10M | 9.1M | 1.12 | |
| Occidental Petroleum Corporation (OXY) | 0.4 | $10M | 173k | 58.88 | |
| ConocoPhillips (COP) | 0.4 | $10M | 111k | 89.81 | |
| Heron Therapeutics (HRTX) | 0.3 | $9.1M | 3.3M | 2.79 | |
| Biohaven Pharmaceutical Holding | 0.3 | $9.0M | 62k | 145.71 | |
| Alvotech Ordinary Shares (ALVO) | 0.3 | $8.2M | 1.0M | 8.21 | |
| Otonomy | 0.2 | $6.5M | 3.1M | 2.08 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $5.7M | 1.3M | 4.48 | |
| Cogent Biosciences (COGT) | 0.2 | $5.4M | 600k | 9.02 | |
| Research Alliance Corp Ii Com Cl A | 0.2 | $4.9M | 500k | 9.80 | |
| Inflarx Nv (IFRX) | 0.2 | $4.8M | 3.3M | 1.45 | |
| Bolt Biotherapeutics (BOLT) | 0.2 | $4.5M | 2.2M | 2.04 | |
| Atai Life Sciences Nv SHS (ATAI) | 0.2 | $4.4M | 1.2M | 3.64 | |
| Gemini Therapeutics | 0.2 | $4.0M | 2.4M | 1.69 | |
| Ambrx Biopharma Sponsored Ads | 0.2 | $4.0M | 1.5M | 2.65 | |
| Solid Biosciences | 0.1 | $3.1M | 5.1M | 0.62 | |
| Terns Pharmaceuticals (TERN) | 0.1 | $3.1M | 1.2M | 2.48 | |
| Omega Alpha Spac Cl A | 0.1 | $3.0M | 300k | 9.85 | |
| European Biotech Acqutn Corp Class A Ord Shs | 0.1 | $2.9M | 300k | 9.79 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.1 | $2.9M | 59k | 48.76 | |
| Roivant Sciences SHS (ROIV) | 0.1 | $2.8M | 682k | 4.07 | |
| Molecular Partners Ads (MOLN) | 0.1 | $2.7M | 400k | 6.78 | |
| Sio Gene Therapies Common | 0.1 | $2.1M | 5.9M | 0.36 | |
| Aeglea Biotherapeutics | 0.1 | $2.1M | 4.1M | 0.51 | |
| Turmeric Acquisition Corp Cl A | 0.1 | $2.0M | 200k | 9.93 | |
| Bcls Acquisition Corp Com Cl A | 0.1 | $2.0M | 200k | 9.90 | |
| Opy Acquisition Corp I Com Cl A | 0.1 | $2.0M | 200k | 9.84 | |
| Entrada Therapeutics (TRDA) | 0.0 | $1.3M | 106k | 12.18 | |
| Immuneering Corp Class A Com (IMRX) | 0.0 | $1.1M | 200k | 5.41 | |
| Eucrates Biomedical Acqu Cor SHS | 0.0 | $990k | 100k | 9.90 | |
| Benitec Biopharma | 0.0 | $892k | 769k | 1.16 | |
| Frazier Lifesciences Acqu Cl A Shs | 0.0 | $864k | 88k | 9.87 | |
| Cano Health *w Exp 06/03/202 (CANWQ) | 0.0 | $257k | 379k | 0.68 | |
| Opy Acquisition Corp I *w Exp 09/22/202 | 0.0 | $18k | 73k | 0.25 | |
| Turmeric Acquisition Corp *w Exp 10/08/202 | 0.0 | $4.0k | 53k | 0.08 |
